25th Jan 2024 The TROPiCS-02 study: a plain language summary on the effectiveness of sacituzumab govitecan in treating HR-positive/HER2-negative breast cancer
11th Sep 2023 A plain language summary of the INTRIGUE study comparing ripretinib with sunitinib in people with advanced gastrointestinal stromal tumour after treatment with imatinib
23rd May 2023 Plain Language Summary: tepotinib, a treatment for a subtype of non-small cell lung cancer called MET exon 14 skipping
18th Oct 2021 Ripretinib for advanced gastrointestinal stromal tumor: Plain language summary of the INVICTUS study